| Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond P Rao, EE Knaus Journal of pharmacy & pharmaceutical sciences 11 (2), 81s-110s, 2008 | 1102 | 2008 |
| Design and synthesis of celecoxib and rofecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of sulfonamide and methylsulfonyl pharmacophores by an … AG Habeeb, PN Praveen Rao, EE Knaus Journal of Medicinal Chemistry 44 (18), 3039-3042, 2001 | 293 | 2001 |
| Design and synthesis of 4, 5-diphenyl-4-isoxazolines: novel inhibitors of cyclooxygenase-2 with analgesic and antiinflammatory activity AG Habeeb, PN Praveen Rao, EE Knaus Journal of medicinal chemistry 44 (18), 2921-2927, 2001 | 248 | 2001 |
| Amyloid cascade in Alzheimer's disease: Recent advances in medicinal chemistry T Mohamed, A Shakeri, PPN Rao European journal of medicinal chemistry 113, 258-272, 2016 | 219 | 2016 |
| Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1, 2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release … C Velázquez, PN Praveen Rao, EE Knaus Journal of medicinal chemistry 48 (12), 4061-4067, 2005 | 142 | 2005 |
| Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 … PN Praveen Rao, M Amini, H Li, AG Habeeb, EE Knaus Journal of medicinal chemistry 46 (23), 4872-4882, 2003 | 135 | 2003 |
| Curcumin binding to beta amyloid: a computational study PPN Rao, T Mohamed, K Teckwani, G Tin Chemical biology & drug design 86 (4), 813-820, 2015 | 130 | 2015 |
| Nonsteroidal anti-inflammatory drugs (NSAIDs): progress in small molecule drug development PPN Rao, SN Kabir, T Mohamed Pharmaceuticals 3 (5), 1530-1549, 2010 | 126 | 2010 |
| Anti-amyloid aggregation activity of natural compounds: implications for Alzheimer’s drug discovery XL Bu, PPN Rao, YJ Wang Molecular neurobiology 53, 3565-3575, 2016 | 114 | 2016 |
| Synthesis and structure− activity relationship studies of 1, 3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases PN Praveen Rao, QH Chen, EE Knaus Journal of medicinal chemistry 49 (5), 1668-1683, 2006 | 111 | 2006 |
| Synthesis and biological evaluation of 1, 3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1/-2 inhibitors A Zarghi, T Zebardast, F Hakimion, FH Shirazi, PNP Rao, EE Knaus Bioorganic & medicinal chemistry 14 (20), 7044-7050, 2006 | 103 | 2006 |
| 2,4-Disubstituted quinazolines as amyloid-β aggregation inhibitors with dual cholinesterase inhibition and antioxidant properties: Development and structure … T Mohamed, PPN Rao European journal of medicinal chemistry 126, 823-843, 2017 | 98 | 2017 |
| Design, synthesis, and structure− activity relationship studies of 3, 4, 6-triphenylpyran-2-ones as selective cyclooxygenase-2 inhibitors PNP Rao, MJ Uddin, EE Knaus Journal of Medicinal Chemistry 47 (16), 3972-3990, 2004 | 90 | 2004 |
| O2-Acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO–NSAIDs): Synthesis, nitric oxide release, and biological evaluation studies CA Velázquez, PNP Rao, ML Citro, LK Keefer, EE Knaus Bioorganic & medicinal chemistry 15 (14), 4767-4774, 2007 | 87 | 2007 |
| Design and synthesis of novel celecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of the sulfonamide pharmacophore by a sulfonylazide bioisostere MJ Uddin, PNP Rao, EE Knaus Bioorganic & medicinal chemistry 11 (23), 5273-5280, 2003 | 81 | 2003 |
| Synthesis and biological evaluation of 3, 4-diphenyl-1, 2, 5-oxadiazole-2-oxides and 3, 4-diphenyl-1, 2, 5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents C Velázquez, PNP Rao, R McDonald, EE Knaus Bioorganic & medicinal chemistry 13 (8), 2749-2757, 2005 | 80 | 2005 |
| Alzheimer's disease: emerging trends in small molecule therapies T Mohamed, P PN Rao Current medicinal chemistry 18 (28), 4299-4320, 2011 | 78 | 2011 |
| Tau-Derived-Hexapeptide 306VQIVYK311 Aggregation Inhibitors: Nitrocatechol Moiety as A Pharmacophore In Drug Design T Mohamed, T Hoang, M Jelokhani-Niaraki, PPN Rao ACS chemical neuroscience 4 (12), 1559-1570, 2013 | 77 | 2013 |
| Development and evaluation of multifunctional agents for potential treatment of Alzheimer’s disease: application to a pyrimidine-2, 4-diamine template T Mohamed, JCK Yeung, MS Vasefi, MA Beazely, PPN Rao Bioorganic & medicinal chemistry letters 22 (14), 4707-4712, 2012 | 75 | 2012 |
| Droplet microfluidic system with on-demand trapping and releasing of droplet for drug screening applications M Courtney, X Chen, S Chan, T Mohamed, PPN Rao, CL Ren Analytical chemistry 89 (1), 910-915, 2017 | 74 | 2017 |
